Produit
AGENTS IA
APPLICATIONS DE L'IA
AUTRES
Solutions
SECTEURS D'ACTIVITÉ
Tarification
Ressources
EXPLORER
ENGAGER
ASSISTANCE ET SERVICES
À propos
Plateforme PatSnap Eureka
Mandataires en propriété intellectuelle
Agents pour l'ingénierie
Agents pour les sciences de la vie
Agents pour matériaux
Analytique
Intelligence IPSynapse
Renseignement biopharmaceutiqueBiographie
Recherche et analyse de séquences biologiquesChimique
Recherche et analyse de structures chimiquesEureka AI à l'intérieur
Services professionnels
Témoignages clients
Blog
Rapport mondial sur l'innovation
Glossaire
Newsroom
Webinaires et formations
Frontière
Communauté d'utilisateurs
Confiance et sécurité
PatentBench
LLM
Centre d'aide
Carrières
Accès à plus de 2 000 000 000 points de données structurées dans les domaines des brevets, des sciences, des litiges et des technologies.
Innovez 75 % plus vite à un coût réduit de 25 %.
Cloud ou sur site pour une confidentialité et un contrôle maximaux
Reconnu par plus de 18 000 innovateurs à travers le monde
Pour l'utiliser, cliquez sur le bouton de vérification dans l'e-mail que nous avons envoyé à [email protected].
Cela contribue à sécuriser votre compte.
Vous devriez le recevoir sous peu. N'oubliez pas de vérifier votre dossier spam.
Unlock professional features and history
Already have an account? Log In
To start using PatSnap Eureka, click the verification button in the email we sent to .
This helps keep your account secure.
Haven't received it? Check your spam folder.
Série soigneusement sélectionnée offrant des informations précieuses aux professionnels de l'innovation.
Article | Rapport Explore the 2026 QDIP technology landscape: material systems, patent clusters, geographic trends, and emerging directions in infrared photodetector innovation.
Article | Rapport How substrate noise coupling degrades RF performance in bulk CMOS versus SOI technology for 5G transceivers — mechanisms, data, and patented mitigation strategies.
Article | Rapport How STING agonists, RIG-I activators, ENPP1 inhibitors, and advanced delivery platforms are reprogramming the tumor microenvironment in solid tumors.
Article | Rapport Enzymes, engineered microbes, and hybrid electro-biological systems are rewriting the carbon capture playbook. Explore the 2026 biocatalytic CO₂ technology landscape.
Article | Rapport How substrate noise coupling degrades RF performance in bulk CMOS versus SOI technology for 5G transceivers—mechanisms, circuit impacts, and patented mitigation strategies.
Article | Rapport Enzymes, engineered microbes, and hybrid electro-biological systems are reshaping CO₂ capture. Explore the 2026 biocatalytic carbon capture technology landscape.
Article | Rapport Explore the NK cell therapy pipeline across hematologic and solid tumors — CAR-NK, iPSC-derived, CIML, and NK engager strategies shaping immuno-oncology in 2025.
Article | Rapport How directed self-assembly (DSA) complements EUV lithography for sub-30 nm contact hole patterning at 3–5 nm nodes. Key materials, process strategies, and IP landscape.
Article | Rapport How CAR-NK, allogeneic, and iPSC-derived NK cell therapies are reshaping immuno-oncology — covering AML, solid tumors, and the evolving target landscape.
Article | Rapport How DSA complements EUV lithography for sub-30 nm contact hole patterning: block copolymers, neutral layers, DSA-OPC, and density multiplication at 3–5 nm nodes.
Article | Rapport Microplasma technology is reshaping biomedical, environmental, and semiconductor sectors. Explore the 2026 patent and innovation landscape with PatSnap.
Article | Rapport How do static and dynamic DRAM refresh strategies differ for automotive-grade LPDDR5? Analysis of 45+ patents covering power, reliability, and ISO 26262 compliance.
Article | Rapport How do static and dynamic DRAM refresh strategies differ for automotive-grade LPDDR5? Analysis of 45+ patents covering temperature-compensation, PASR, ECC, and ADAS reliability.
Article | Rapport Zinc ion batteries are emerging as a post-lithium storage platform. Explore the 2026 technology landscape: cathode materials, anode stabilization, electrolyte IP, and grid-scale applications.
Article | Rapport Trispecific antibodies targeting CD38, BCMA, and CD3 are emerging as the next frontier in multiple myeloma therapy. Explore the patent pipeline, key players, and clinical signals.